Rituxan (rituximab) - Biogen, Zenyaku Holdings, Roche
Coversin SC (nomacopan SC) - Akari Therap
Xolair (omalizumab) - Roche, Novartis
bertilimumab (iCo-008) - Satellos Biosci, AstraZeneca
Fasenra (benralizumab) - AstraZeneca
Dupixent (dupilumab) - Sanofi, Regeneron
Vyvgart (efgartigimod alfa-fcab) - argenx, Broteio
http://www.ncbi.nlm.nih.gov/pubmed/37526503
 
Christian D Sadik; Enno Schmidt; Henning Olbrich
 
Aug 1, 2023
 
Prev Next